05/15/2025 10:39 AM | Kynam Capital Management, LP (Filed by) Sutro Biopharma (Subject)
| Form SCHEDULE 13G | |
05/08/2025 3:28 PM | Sutro Biopharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/08/2025 3:30 PM | Sutro Biopharma (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
05/05/2025 4:45 PM | Borgman Anne Elizabeth (Reporting) Sutro Biopharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/05/2025 4:46 PM | Srinivasan Venkatesh (Reporting) Sutro Biopharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/05/2025 4:48 PM | FITZPATRICK LINDA A (Reporting) Sutro Biopharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/25/2025 3:30 PM | Sutro Biopharma (Filer)
| Form DEF 14A | |
04/25/2025 3:33 PM | Sutro Biopharma (Filer)
| Form DEFA14A | |
04/25/2025 3:33 PM | Sutro Biopharma (Filer)
| Form ARS | |
04/17/2025 8:35 AM | BlackRock, Inc. (Filed by) Sutro Biopharma (Subject)
| Form SCHEDULE 13G/A | |
04/08/2025 3:03 PM | Pauling David (Reporting) Sutro Biopharma (Issuer)
| Form 3 Initial statement of beneficial ownership of securities | |
Get the Latest News and Ratings for STRO and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Sutro Biopharma and its competitors with MarketBeat's FREE daily newsletter.
|
04/08/2025 3:05 PM | Pauling David (Reporting) Sutro Biopharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/08/2025 3:07 PM | Srinivasan Venkatesh (Reporting) Sutro Biopharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/08/2025 3:09 PM | Leyman Barbara (Reporting) Sutro Biopharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/08/2025 3:11 PM | Gerber Hans-Peter (Reporting) Sutro Biopharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/08/2025 3:12 PM | Chung Jane (Reporting) Sutro Biopharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/04/2025 3:32 PM | RA CAPITAL MANAGEMENT, L.P. (Filed by) Sutro Biopharma (Subject)
| Form SCHEDULE 13G | |
03/13/2025 4:14 PM | Sutro Biopharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/13/2025 4:17 PM | Sutro Biopharma (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
03/07/2025 3:14 PM | NEWELL WILLIAM J (Reporting) Sutro Biopharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/06/2025 3:06 PM | Chung Jane (Reporting) Sutro Biopharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/06/2025 3:09 PM | NEWELL WILLIAM J (Reporting) Sutro Biopharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/06/2025 3:12 PM | FITZPATRICK LINDA A (Reporting) Sutro Biopharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/04/2025 5:32 PM | NEWELL WILLIAM J (Reporting) Sutro Biopharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/04/2025 5:34 PM | Gerber Hans-Peter (Reporting) Sutro Biopharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/04/2025 5:40 PM | FITZPATRICK LINDA A (Reporting) Sutro Biopharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/04/2025 5:42 PM | Chung Jane (Reporting) Sutro Biopharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/04/2025 5:44 PM | ALBINI EDWARD C (Reporting) Sutro Biopharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/04/2025 4:57 PM | Borgman Anne Elizabeth (Reporting) Sutro Biopharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/04/2025 4:58 PM | Srinivasan Venkatesh (Reporting) Sutro Biopharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/27/2025 3:30 PM | Sutro Biopharma (Filer)
| Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
12/10/2024 7:00 AM | Sutro Biopharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/14/2024 6:54 PM | Point72 Asset Management, L.P. (Filed by) Sutro Biopharma (Subject)
| Form SC 13G/A | |
11/13/2024 3:30 PM | Rubric Capital Management LP (Filed by) Sutro Biopharma (Subject)
| Form SC 13G/A | |
11/13/2024 3:34 PM | Sutro Biopharma (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
11/12/2024 8:34 AM | Adage Capital Management, L.P. (Filed by) Sutro Biopharma (Subject)
| Form SC 13G/A | |
11/04/2024 1:09 PM | Sutro Biopharma (Subject) VANGUARD GROUP INC (Filed by)
| Form SC 13G/A | |
08/13/2024 3:31 PM | Sutro Biopharma (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
08/13/2024 3:16 PM | Chung Jane (Reporting) Sutro Biopharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/12/2024 3:38 PM | Jagpal Sukhi (Reporting) Sutro Biopharma (Issuer)
| Form 3 Initial statement of beneficial ownership of securities | |
08/12/2024 3:40 PM | Jagpal Sukhi (Reporting) Sutro Biopharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
Market chaos is the new normal (Ad) It happened again.
Wall Street swung like a wrecking ball after Trump paused tariffs on smartphones, laptops, and semiconductors.
Tech stocks surged—but not because the economy is stable. It’s because investors are panicking over trade policy whiplash.
And here’s the hard truth:
If your retirement is too tied to stocks, you’re exposed.  Claim your free, no-strings-attached 2025 Ultimate Guide to Gold IRAs right now. |
07/10/2024 3:10 PM | Leyman Barbara (Reporting) Sutro Biopharma (Issuer)
| Form 3 Initial statement of beneficial ownership of securities | |
07/10/2024 3:11 PM | Leyman Barbara (Reporting) Sutro Biopharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/10/2024 3:29 PM | Petree Daniel H (Reporting) Sutro Biopharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/10/2024 3:30 PM | Sutro Biopharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/10/2024 3:31 PM | Sutro Biopharma (Issuer) Wigginton Jon Marc (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/10/2024 3:19 PM | Dybbs Michael (Reporting) Sutro Biopharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/10/2024 3:21 PM | Freund John Gordon (Reporting) Sutro Biopharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/10/2024 3:22 PM | Hunter Heidi (Reporting) Sutro Biopharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/10/2024 3:24 PM | Lobacki Joseph M (Reporting) Sutro Biopharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |